Juvenile Offender HIV Prevention and Drug Abuse Services (Day Treatment)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Howard Liddle, University of Miami
ClinicalTrials.gov Identifier:
NCT01922297
First received: August 10, 2013
Last updated: May 21, 2014
Last verified: May 2014
  Purpose

This study will determine the clinical effectiveness, moderators and mechanisms of change, and economic impact of an integrative, family-based intervention that concurrently targets change in HIV/Sexually Transmitted Disease (STD)-associated risk behaviors, drug abuse, delinquency, arrest and mental health outcomes for juvenile offenders committed to a juvenile justice day treatment program.


Condition Intervention
Risk Behavior
Substance Abuse
Delinquency
Other: Day Treatment MDFT-HIV
Other: Day Treatment SAU

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Factorial Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Juvenile Offender HIV Prevention and Drug Abuse Services

Resource links provided by NLM:


Further study details as provided by University of Miami:

Primary Outcome Measures:
  • Substance Use [ Time Frame: Changes in substance use from intake through the 24-month follow-up ] [ Designated as safety issue: No ]
    The Timeline Follow-Back Method, Personal Experiences Inventory and Urinalyses will be used to measure substance use


Secondary Outcome Measures:
  • HIV Associated Sexual Risk Behaviors [ Time Frame: Changes in HIV Associated Sexual Risk Behaviors from intake to the 24-month follow-up ] [ Designated as safety issue: No ]
    Timeline Followback for Sexual Risk Behavior, Urinalysis for STD testing and HIV/STD Risk Assessment Measure

  • Delinquency [ Time Frame: Changes in delinquency from intake through the 24-month follow-up ] [ Designated as safety issue: No ]
    Juvenile Justice records and the Service Utilization Interview


Enrollment: 121
Study Start Date: January 2010
Estimated Study Completion Date: May 2014
Estimated Primary Completion Date: May 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Day Treatment MDFT-HIV
Multidimensional Family Therapy (MDFT)is an integrative treatment approach that has blended family therapy, individual therapy, drug counseling, and multiple systems oriented intervention approaches (Liddle 1999). DT-MDFT-HIV includes a state-of-the-art family-based HIV prevention component into the core MDFT intervention specifically targeting high-risk sexual behavior in clinical sample teens.
Other: Day Treatment MDFT-HIV
MDFT-HIV is a specialized intervention aimed at reducing risk factors for HIV-associated sexual behaviors. It builds protective behaviors in the adolescent's intrapersonal and interpersonal functioning, as well as those aspects of family functioning to reduce youths' high-risk sexual behavior. For instance, interventions target inadequate monitoring, parent-adolescent conflict, and parental disengagement - behaviors consistently associated with elevated HIV/STD risk. It facilitates positive and supportive family relationships, processes that can significantly reduce HIV/STD risk. Additionally, it aims to promote effective family communication about sexuality and safer sexual behaviors, among the most important protective factors against sexual risk taking behavior.
Other Name: DT-MDFT-HIV
Day Treatment SAU
The DT-Services as Usual (SAU) condition is primarily a peer group-based and individual approach that uses cognitive-behavioral principles and interventions. It is an adolescent substance abuse treatment and services consistent with those recommended for juvenile justice-involved drug abusing youth (Cooper & Bartlett 1998; National Institute of Justice, 2001).
Other: Day Treatment SAU
Substance abuse treatment and HIV prevention services are routinely provided to youth in the day treatment programs. The day treatment programs contract to local substance abuse and mental health providers for these services that are provided both within and outside of the day treatment setting. The intervention's specific features are similar to those found in the literature on outpatient peer-based group treatment for adolescent alcohol abusers (CSAT 1998). Specifically, it is based on a cognitive-behavioral group treatment model (Kaminer et al 1998; Marshall & Marshall 1993), with a comprehensive treatment package including individual counseling and treatment planning.
Other Name: DT-SAU

  Show Detailed Description

  Eligibility

Ages Eligible for Study:   13 Years to 18 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Between the ages of 13 and 18
  • Committed to a juvenile justice day treatment program
  • Meet criteria for substance use disorder on the DISC Predictive Scales
  • Any self-reported sexual activity within the past 6 months
  • At least one parent figure willing to participate in intervention and assessments

Exclusion Criteria:

  • Mental retardation or pervasive developmental disorders
  • Psychotic features
  • Current suicidality defined as Ideation + Plan + High intention to carry out plan
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01922297

Locations
United States, Florida
University of Miami Miller School of Medicine
Miami, Florida, United States, 33136
Sponsors and Collaborators
University of Miami
Investigators
Principal Investigator: Howard A Liddle, EdD University of Miami
  More Information

No publications provided

Responsible Party: Howard Liddle, Professor, University of Miami
ClinicalTrials.gov Identifier: NCT01922297     History of Changes
Other Study ID Numbers: 20090438, R01DA027216
Study First Received: August 10, 2013
Last Updated: May 21, 2014
Health Authority: United States: Institutional Review Board
United States: Federal Government

Keywords provided by University of Miami:
Delinquency
HIV Associated Risk Behavior
Juveniles
Family based treatment
Multidimensional Family Therapy

Additional relevant MeSH terms:
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders

ClinicalTrials.gov processed this record on August 19, 2014